Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella N Hoogenboezem

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|July 18, 2018
Harnessing albumin as a carrier for cancer therapiesElla N Hoogenboezem, Craig L Duvall
Cellular and Molecular Bioengineering|April 11, 2022
Albumin-Binding Aptamer Chimeras for Improved siRNA BioavailabilityJonah C Rosch, Ella N Hoogenboezem, Alexander G Sorets, et al.
The Spine Journal : Official Journal of the North American Spine Society|December 20, 2016
Creation of an injectable in situ gelling native extracellular matrix for nucleus pulposus tissue engineeringRebecca A Wachs, Ella N Hoogenboezem, Hammad I Huda, et al.
Biomaterials|November 21, 2018
Dual carrier-cargo hydrophobization and charge ratio optimization improve the systemic circulation and safety of zwitterionic nano-polyplexesMeredith A Jackson, Sean K Bedingfield, Fang Yu, et al.
Biomaterials|April 9, 2023
Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencingShrusti S Patel, Ella N Hoogenboezem, Fang Yu, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrierAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.
Cancer Research Communications|February 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineShrusti S Patel, Rebecca S Cook, Justin H Lo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 13, 2025
Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrierAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.
Biomaterials|December 7, 2020
Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriersMeredith A Jackson, Shrusti S Patel, Fang Yu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Albumin-binding RNAi Conjugate for Carrier Free Treatment of ArthritisJuan M Colazo, Ella N Hoogenboezem, Megan C Keech, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|July 18, 2018
Harnessing albumin as a carrier for cancer therapiesElla N Hoogenboezem, Craig L Duvall
Cellular and Molecular Bioengineering|April 11, 2022
Albumin-Binding Aptamer Chimeras for Improved siRNA BioavailabilityJonah C Rosch, Ella N Hoogenboezem, Alexander G Sorets, et al.
The Spine Journal : Official Journal of the North American Spine Society|December 20, 2016
Creation of an injectable in situ gelling native extracellular matrix for nucleus pulposus tissue engineeringRebecca A Wachs, Ella N Hoogenboezem, Hammad I Huda, et al.
Biomaterials|November 21, 2018
Dual carrier-cargo hydrophobization and charge ratio optimization improve the systemic circulation and safety of zwitterionic nano-polyplexesMeredith A Jackson, Sean K Bedingfield, Fang Yu, et al.
Biomaterials|April 9, 2023
Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencingShrusti S Patel, Ella N Hoogenboezem, Fang Yu, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrierAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.
Cancer Research Communications|February 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineShrusti S Patel, Rebecca S Cook, Justin H Lo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 13, 2025
Intravenous lipid-siRNA conjugate mediates gene silencing at the blood-brain barrier and blood-CSF barrierAlexander G Sorets, Katrina R Schwensen, Nora Francini, et al.
Biomaterials|December 7, 2020
Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriersMeredith A Jackson, Shrusti S Patel, Fang Yu, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Albumin-binding RNAi Conjugate for Carrier Free Treatment of ArthritisJuan M Colazo, Ella N Hoogenboezem, Megan C Keech, et al.
Pageof 2